About: Ponesimod     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : dbo:Drug, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon
http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FPonesimod&invfp=IFP_OFF&sas=SAME_AS_OFF

Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS). The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension. Ponesimod was approved for medical use in the United States in March 2021 and in the European Union in June 2021.

AttributesValues
rdf:type
rdfs:label
  • Ponesimod (de)
  • Ponésimod (fr)
  • Ponesimod (en)
rdfs:comment
  • Ponesimod ist ein Arzneistoff aus der Gruppe der Immunmodulatoren, der zur oralen Behandlung der multiplen Sklerose (MS) eingesetzt wird. (de)
  • Le ponésimod est un modulateur des récepteurs à la sphingosine-1-phosphate de type 1 (S1PR1) et est en cours de test dans la sclérose en plaques et le psoriasis. (fr)
  • Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS). The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension. Ponesimod was approved for medical use in the United States in March 2021 and in the European Union in June 2021. (en)
foaf:depiction
  • http://commons.wikimedia.org/wiki/Special:FilePath/Ponesimod.svg
  • http://commons.wikimedia.org/wiki/Special:FilePath/Ponesimod_ball-and-stick_model.png
dcterms:subject
Wikipage page ID
Wikipage revision ID
Link from a Wikipage to another Wikipage
Link from a Wikipage to an external page
sameAs
dbp:wikiPageUsesTemplate
thumbnail
ATC suffix
  • AA50 (en)
ATC prefix
  • L04 (en)
c
CAS number
ChEMBL
ChemSpiderID
Cl
DrugBank
  • DB12016 (en)
elimination half-life
excretion
  • Feces , urine (en)
H
image
  • Ponesimod ball-and-stick model.png (en)
IUPAC name
KEGG
  • D11215 (en)
legal US
  • Rx-only (en)
metabolism
n
O
PubChem
routes of administration
s
SMILES
  • CCC/N=C\1/NC3=CC=CC=C3C (en)
StdInChI
StdInChIKey
  • LPAUOXUZGSBGDU-STDDISTJSA-N (en)
synonyms
  • ACT-128800 (en)
tradename
  • Ponvory (en)
UNII
width
has abstract
  • Ponesimod ist ein Arzneistoff aus der Gruppe der Immunmodulatoren, der zur oralen Behandlung der multiplen Sklerose (MS) eingesetzt wird. (de)
  • Le ponésimod est un modulateur des récepteurs à la sphingosine-1-phosphate de type 1 (S1PR1) et est en cours de test dans la sclérose en plaques et le psoriasis. (fr)
  • Ponesimod, sold under the brand name Ponvory, is a medication for the treatment of multiple sclerosis (MS). The most common side effects include upper respiratory tract infection, hepatic transaminase elevation, and hypertension. Ponesimod was approved for medical use in the United States in March 2021 and in the European Union in June 2021. (en)
DailyMedID
  • Ponesimod (en)
legal AU
  • S4 (en)
legal CA
  • Rx-only (en)
legal EU
  • Rx-only (en)
pregnancy AU
  • D (en)
gold:hypernym
prov:wasDerivedFrom
page length (characters) of wiki page
Faceted Search & Find service v1.17_git139 as of Feb 29 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 56 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software